During the past decade, Zuyderland Medisch Centrum conducted 138 clinical trials. In the 10-year time frame, 138 clinical trials started and 46 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 73 clinical trials started and 30 clinical trials were completed. i.e. 41.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zuyderland Medisch Centrum" #1 sponsor was "Zuyderland Medisch Centrum" with 26 trials, followed by "Hoffmann-La Roche" with 19 trials sponsored, "Maastricht University Medical Center" with 15 trials sponsored, "Boehringer Ingelheim" with 12 trials sponsored and "Celgene" with 12 trials sponsored. Other sponsors include 122 different institutions and companies that sponsored additional 81 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zuyderland Medisch Centrum" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 12 trials as a collaborator, "Maastricht University Medical Center" with 8 trials as a collaborator, "Borstkanker Onderzoek Groep" with 5 trials as a collaborator, "Dutch Cancer Society" with 5 trials as a collaborator and "Zuyderland Medical Centre" with 5 trials as a collaborator. Other collaborators include 190 different institutions and companies that were collaborators in the rest 168 trials.

According to Clinical.Site data, the most researched conditions in "Zuyderland Medisch Centrum" are "Breast Cancer" (14 trials), "Crohn Disease" (8 trials), "Atrial Fibrillation" (7 trials), "Multiple Sclerosis" (6 trials) and "Prostate Cancer" (6 trials). Many other conditions were trialed in "Zuyderland Medisch Centrum" in a lesser frequency.

Most popular intervention types in "Zuyderland Medisch Centrum" are "Drug" (129 trials), "Other" (36 trials), "Procedure" (19 trials), "Device" (17 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (36 trials), "Atezolizumab" (5 trials), "Dexamethasone" (5 trials), "Ocrelizumab" (5 trials) and "Ozanimod" (4 trials). Other intervention names were less common.

The vast majority of trials in "Zuyderland Medisch Centrum" are 166 trials for "All" genders, 30 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are 69 active trials in "Zuyderland Medisch Centrum". 2 are not yet recruiting, 42 are recruiting, 24 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 106 completed trials in Zuyderland Medisch Centrum, undefined suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Zuyderland Medisch Centrum, 0 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 20 trials, and there were also 41 trials that are defined as “Not Applicable".